GLENMARK
Invest Now
Glenmark Pharmaceuticals Share Price
₹1,463.50 -29.15 (-1.95%)
21 Nov, 2024 14:40
Start SIP in GLENMARK
Start SIPPerformance
- Low
- ₹1,459
- High
- ₹1,494
- 52 Week Low
- ₹761
- 52 Week High
- ₹1,831
- Open Price₹1,493
- Previous Close₹1,493
- Volume326,994
Investment Returns
- Over 1 Month -15.82%
- Over 3 Month -10.65%
- Over 6 Month + 40.39%
- Over 1 Year + 86.39%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -47.2
- PEG Ratio
- 0.1
- Market Cap Cr
- 41,298
- P/B Ratio
- 5.3
- Average True Range
- 63.48
- EPS
- 0
- Dividend Yield
- 0.2
- MACD Signal
- -25.02
- RSI
- 29.79
- MFI
- 23.03
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,463.50
-29.15
(-1.95%)
- Bullish Moving Average 3
- Bearish Moving Average 13
- 20 Day
- ₹1,626.92
- 50 Day
- ₹1,644.16
- 100 Day
- ₹1,557.05
- 200 Day
- ₹1,365.82
Resistance and Support
1494.57
- R3 1,560.13
- R2 1,538.92
- R1 1,515.78
- S1 1,471.43
- S2 1,450.22
- S3 1,427.08
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results | |
2024-08-14 | Quarterly Results | |
2024-05-24 | Audited Results & Final Dividend | |
2024-02-14 | Quarterly Results | |
2023-11-10 | Quarterly Results |
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹1,463 As on 21 November, 2024 | 14:26
The Market Cap of Glenmark Pharmaceuticals is ₹41298.2 Cr As on 21 November, 2024 | 14:26
The P/E ratio of Glenmark Pharmaceuticals is -47.2 As on 21 November, 2024 | 14:26
The PB ratio of Glenmark Pharmaceuticals is 5.3 As on 21 November, 2024 | 14:26
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.